A gene for achondroplasia–hypochondroplasia maps to chromosome 4p
暂无分享,去创建一个
Jean Weissenbach | Arnold Munnich | Martine Le Merrer | Marek Sanak | J. Weissenbach | A. Munnich | M. Sanak | J. Bonaventure | L. Legeai-Mallet | A. Pelet | Laurence Legeai-Mallet | Francis Rousseau | F. Rousseau | M. Merrer | P. Maroteaux | Anna Pelet | Jacky Bonaventure | Jean-Christophe Landais | Claude Stoll | Pierre Maroteaux | C. Stoll | J. Landais
[1] V. McKusick,et al. Observations Suggesting Allelism of the Achondroplasia and Hypochondroplasia Genes , 1973, Journal of medical genetics.
[2] S. Pulst,et al. Molecular analysis of a patient with neurofibromatosis 1 and achondroplasia. , 1991, American journal of medical genetics.
[3] E. Castilla,et al. The birth prevalence rates for the skeletal dysplasias. , 1986, Journal of medical genetics.
[4] T. Maciag,et al. The heparin-binding (fibroblast) growth factor family of proteins. , 1989, Annual review of biochemistry.
[5] J. T. Thomas,et al. SSCP and segregation analysis of the human type X collagen gene (COL10A1) in heritable forms of chondrodysplasia. , 1992, American journal of human genetics.
[6] G. Gyapay,et al. A second-generation linkage map of the human genome , 1992, Nature.
[7] E. Ippolito,et al. Histochemistry and ultrastructure of the growth plate in achondroplasia. , 1981, The Journal of bone and joint surgery. American volume.
[8] P. Falzon,et al. [Hypochondroplasia. Review of 80 cases]. , 1988, Archives francaises de pediatrie.
[9] J. Ott,et al. Multilocus linkage analysis in humans: detection of linkage and estimation of recombination. , 1985, American journal of human genetics.
[10] P. Hindmarsh,et al. Growth characteristics and response to growth hormone therapy in patients with hypochondroplasia: genetic linkage of the insulin‐like growth factor I gene at chromosome 12q23 to the disease in a subgroup of these patients , 1991, Clinical endocrinology.
[11] K. K. Smith,et al. Achondroplasia—a genetic and statistical survey , 1970, Annals of human genetics.
[12] M. Hayman,et al. Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[13] P. Maroteaux,et al. Homozygous achondroplasia: morphologic and biochemical study of cartilage. , 1990, American journal of medical genetics.
[14] D. Housman,et al. A gene encoding a fibroblast growth factor receptor isolated from the Huntington disease gene region of human chromosome 4. , 1991, Genomics.
[15] D. Kowbel,et al. Genomic organization and complete sequence of the human gene encoding the β-subunit of the cGMP phosphodiesterase and its localisation to 4p16.3 , 1991 .
[16] G. Lathrop,et al. Easy calculations of lod scores and genetic risks on small computers. , 1984, American journal of human genetics.
[17] F. Collins,et al. Sequence-tagged sites (STSs) spanning 4p16.3 and the Huntington disease candidate region. , 1992, Genomics.
[18] Paul Wordsworth,et al. Evidence against the structural gene encoding type II collagen (COL2A1) as the mutant locus in achondroplasia. , 1986, Journal of medical genetics.
[19] K. Buetow,et al. Characterization of the human HOX 7 cDNA and identification of polymorphic markers. , 1992, Human molecular genetics.
[20] I. Ponseti. Skeletal growth in achondroplasia. , 1970, The Journal of bone and joint surgery. American volume.
[21] H. Lehrach,et al. A zinc-finger gene ZNF141 mapping at 4p16.3/D4S90 is a candidate gene for the Wolf-Hirschhorn (4p-) syndrome. , 1993, Human molecular genetics.
[22] K. Nakashima,et al. Reduction of basic fibroblasts growth factor receptor is coupled with terminal differentiation of chondrocytes. , 1991, The Journal of biological chemistry.
[23] J. Spranger,et al. Hypochondroplasia: clinical and radiological aspects in 39 cases. , 1979, Radiology.
[24] J. Gormley,et al. Achondroplasia and hypochondroplasia. Clinical variation and spinal stenosis. , 1981, The Journal of bone and joint surgery. British volume.
[25] D. Danks,et al. Achondroplasia and hypochondroplasia. Comments on frequency, mutation rate, and radiological features in skull and spine. , 1979, Journal of medical genetics.
[26] M. Iwamoto,et al. Fibroblast growth factor is an inhibitor of chondrocyte terminal differentiation. , 1990, The Journal of biological chemistry.
[27] R. Gardner. A new estimate of the achondroplasia mutation rate , 1977, Clinical genetics.
[28] C. Stoll,et al. Birth prevalence rates of skeletal dysplasias , 1989, Clinical genetics.